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Association between SNAP-25 gene polymorphisms and
cognition in autism: functional consequences and potential
therapeutic strategies
D Braida1,2, FR Guerini2, L Ponzoni1,3, I Corradini4, S De Astis1, L Pattini5, E Bolognesi2, R Benfante4, D Fornasari1,4, M Chiappedi6,
A Ghezzo7,8, M Clerici2,9, M Matteoli1,10 and M Sala1,4
Synaptosomal-associated protein of 25 kDa (SNAP-25) is involved in different neuropsychiatric disorders, including schizophrenia
and attention-deﬁcit/hyperactivity disorder. Consistently, SNAP-25 polymorphisms in humans are associated with hyperactivity
and/or with low cognitive scores. We analysed ﬁve SNAP-25 gene polymorphisms (rs363050, rs363039, rs363043, rs3746544 and
rs1051312) in 46 autistic children trying to correlate them with Childhood Autism Rating Scale and electroencephalogram (EEG)
abnormalities. The functional effects of rs363050 single-nucleotide polymorphism (SNP) on the gene transcriptional activity, by
means of the luciferase reporter gene, were evaluated. To investigate the functional consequences that SNAP-25 reduction may
have in children, the behaviour and EEG of SNAP-25+/− adolescent mice (SNAP-25+/+) were studied. Signiﬁcant association of
SNAP-25 polymorphism with decreasing cognitive scores was observed. Analysis of transcriptional activity revealed that SNP
rs363050 encompasses a regulatory element, leading to protein expression decrease. Reduction of SNAP-25 levels in adolescent
mice was associated with hyperactivity, cognitive and social impairment and an abnormal EEG, characterized by the occurrence of
frequent spikes. Both EEG abnormalities and behavioural deﬁcits were rescued by repeated exposure for 21 days to sodium salt
valproate (VLP). A partial recovery of SNAP-25 expression content in SNAP-25+/− hippocampi was also observed by means of
western blotting. A reduced expression of SNAP-25 is responsible for the cognitive deﬁcits in children affected by autism spectrum
disorders, as presumably occurring in the presence of rs363050(G) allele, and for behavioural and EEG alterations in adolescent
mice. VLP treatment could result in novel therapeutic strategies.
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INTRODUCTION
Recent evidences suggested that SNAP-25 (synaptosomal-asso-
ciated protein of 25 kDa) is involved in different neuropsychiatric
and neurological disorders.1 SNAP-25 participates in the regula-
tion of synaptic vesicle exocytosis through the formation of a
soluble N-ethylmaleimide-sensitive fusion protein-attachment
protein receptor (SNARE) complex2 and interacts with different
types of voltage-gated calcium channels,3 inhibiting their function
and thus reducing neuronal calcium responsiveness to
depolarization.4–6
Interestingly, polymorphisms in the SNAP-25 gene as well as
altered expression of the protein have been associated with
abnormal behavioural phenotype in both animal models7–9 and
humans. Polymorphisms in the SNAP-25 gene have been found in
patients affected by attention-deﬁcit/hyperactivity disorder
(ADHD),10–13 schizophrenia14–16 and autism spectrum disorders
(ASDs).17 In a group of Sardinian children who developed primary
ASD, SNAP-25 polymorphisms were associated with a more
compromised clinical outcome,17 and a signiﬁcant correlation
was observed between SNAP-25 single-nucleotide polymorphisms
(SNPs) rs363043 and the Childhood Autism Rating Scale (CARS).
Notably, these correlations were predominantly with hyperactivity
and one or more aspects of the executive functions. SNAP-25 was
also shown to be involved in the differential cognitive ability of
healthy subjects. In particular, four SNAP-25 SNPs (rs363043,
rs353016, rs363039 and rs363050) were associated with an
increment of performance, but not of verbal intelligence
quotient.18
Reduction of SNAP-25 expression has been described in brains
of patients affected by either schizophrenia14 or ADHD.19
Reduction of protein expression was associated with the
occurrence of frequent electroencephalographic spikes, suggest-
ing a diffuse network hyperexcitability as shown in coloboma
mouse20 and SNAP-25 heterozygous mice.21 Interestingly, epilepsy
is associated with several neurodevelopmental disorders including
ADHD, ASD and intellectual disability.22 Such co-occurrence may
share a genetic basis.23 Children and adolescents with epilepsy, in
particular, tend to show an increased risk of ADHD,24,25 suggesting
a strong interrelationship between the ASD and ADHD phenotype
and childhood epilepsy. Notably, the epileptiform activity,
characterized by the occurrence of frequent electroencephalo-
gram (EEG) spikes in 3-month-old SNAP-25+/− mice, was
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accompanied by cognitive deﬁcits that were reverted by
antiepileptic drugs.21
In an attempt to understand more in depth the role of SNAP-25
in human diseases characterized by an abnormal cognitive proﬁle,
we ﬁrst analysed ﬁve SNAP-25 gene polymorphisms (rs363043,
rs363039, rs363050, rs3746544 and rs1051312) in a clinically
characterized cohort of children affected by ASD; in particular, we
evaluated possible associations between such SNPs and the
clinical outcome of ASD. As we found a correlation between
rs363050 SNP and cognitive deﬁcits, the functional effects of this
polymorphism on the gene expression was evaluated by means of
the luciferase reporter gene conﬁrming its involvement in gene
transcriptional modulation. Moreover, given that SNAP-25 expres-
sion can be altered in childhood neuropsychiatric diseases and our
previous work demonstrated behavioural and EEG deﬁcits in adult
SNAP-25+/− mice, we decided to verify whether similar deﬁcits
were present also during adolescence (6 weeks old), in order to
highlight possible autistic or ADHD symptoms. Finally, to verify a
possible therapeutic application of valproate (VLP), which was
previously shown to rescue some behavioural and EEG deﬁcits
when acutely administered, we evaluated the effect of this
antiepileptic drug after chronic exposure.
MATERIALS AND METHODS
Human studies
Subjects. Forty-four Italian ASD patients (40 males, 4 females, mean age
10.9 years; s.d. = 4.7 years) were enroled in the study. All subjects were
born in peninsular Italy from families without Sardinian ancestry and were
of Italian descent. All children underwent an in-depth examination that
included clinical and neurological evaluations, mental status examination
(covering the social interaction, imaginative play, language and commu-
nication domains), neuropsychological evaluation (using the Leiter-R,
Wechsler Intelligence Scale for Children-R, Raven and Vineland Adaptive
Behaviour Scales according to the speciﬁc clinical picture) and other
diagnostic tools, such as the Modiﬁed Checklist for Autism in Toddlers,
CARS, the Australian Scale for Asperger’s syndrome, karyotype and DNA
analysis for fragile X and MeC-P2, screens for inborn errors of metabolism
(phenylketonuria), amino and organic acidopathies, EEG, brain-stem
acoustic evoked potentials, visual evoked responses and computerized
tomography or magnetic resonance imaging; some parents gave their
consent only for computerized tomography rather than for magnetic
resonance imaging. In-depth genetic analyses were performed as well in
these children.26,27
ASD diagnosis was made according to Diagnostic and Statistical Manual
of Mental Disorders (DSM-IV-TR) criteria28 and the children were classiﬁed
as follows: autistic disorder (33 cases, 75%), Asperger’s syndrome (7 cases,
15.9%) and pervasive developmental disorder—not otherwise speciﬁed (4
cases, 0.09%). Children with identiﬁed causes of autistic symptoms (for
example, fragile X syndrome) were excluded from the study. Informed
consent was obtained from all participants/legal guardians prior to
inclusion in the study. The study was approved by the institutional review
board of the Don Carlo Gnocchi ONLUS Foundation, Milan.
SNP typing. Genomic DNA was isolated from peripheral human blood.
Procedural details are reported in Supplementary Materials and Methods.
In vitro studies
Transient transfection and the luciferase assay. The SH-SY5Y human
neuroblastoma cell line was grown in RPMI 1640 medium (Lonza Group,
Basel, Switzerland), supplemented with 10% fetal bovine serum,
100 units/ml penicillin, 100 μgml− 1 streptomycin and 2mM L-glutamine
(Lonza Group). For further details see Supplementary Materials and
Methods.
Animal studies
Subjects. All the experimental procedures followed the guidelines
established by the Italian Council on Animal Care and were approved by
the Italian Government decree No. 27/2010. All efforts were made to
minimize the number of subjects used and their suffering. Male SNAP-25+/+
and SNAP-25+/−C57BL/6 mice were backcrossed and genotyped as
previously reported.21 All mice used were littermates from mated
heterozygous. Animals were individually housed throughout the testing
period with free access to food and water at controlled temperature (20–
22 °C) with a 12-h light/dark cycle (lights on at 0700 hours). Each mouse
was used only once. Animals were randomly assigned to each
experimental group and tested at 6–7 weeks of age (adolescence).
Pharmacological treatment
Mice, at the age of 3 weeks, were exposed 24 h per day for 21 days to VLP
solution (0.1% dissolved in plain water) (Sigma-Aldrich, St Louis, MO, USA)
or water. Each day the bottles containing VLP (or water for the control
animals) were weighted to obtain the daily amount of ﬂuid intake, and
reﬁlled with fresh solution. Twenty-four hours after the last VLP exposure
different groups of mice (10 each) were submitted to behavioural tests
and EEG.
Behavioural assays
Spontaneous motor activity and amphetamine response. Motor function
was evaluated using an activity cage (43 × 43 × 32 cm) (Ugo Basile, Varese,
Italy), placed in a sound-attenuating room. The cage was ﬁtted with two
parallel horizontal infrared beams located 2 cm from the ﬂoor. Before the
start of the test, each mouse (6–7 weeks of age) was habituated to the
testing room for at least 1 h. Cumulative horizontal movement counts were
recorded for 4 h before and 3 h after treatment. Animals were treated
subcutaneously with saline or amphetamine sulphate (4mg kg− 1) (Sigma-
Aldrich) dissolved in 0.9% NaCl, according to Hess et al.29
Object recognition test. The test was conducted over a 2-day period in an
open plastic arena (60 × 50 × 30 cm). Animals were habituated to the test
arena for 10min on the ﬁrst day. After 1-day habituation, mice were
subjected to familiarization (T1) and novel object recognition (T2). The
novel object recognition task was performed as previously described30
using a delay time of 120min. The performance was evaluated by
calculating a discrimination index (N− F/N+F), where N= time spent
exploring the new object during T2, F= time spent exploring the familiar
object during T2.
Conditioned taste aversion. SNAP-25+/+ and SNAP-25+/− mice were singly
housed during the conditioned taste aversion (CTA) test. After mice were
adapted to a restricted drinking schedule (20min h− 1 per day for 4 days),
they were exposed to a saccharin solution (conditioned stimulus, CS; 0.5%)
followed 1 h later by a malaise-inducing injection of LiCl (unconditioned
stimulus, US; 0.14 M, 2% body weight, intraperitoneally) according to
Callaerts-Vegh et al.31 After 24 h of wash-out (drinking water for 30min),
mice could freely choose to drink either saccharin solution or tap water
during three daily choice tests. The mean amount of saccharin intake
expressed as the percentage of total ﬂuid consumed ((saccharin/saccharin
+water) × 100) was taken as an aversion index.
Sociability and preference for the social novelty test. The sociability and
preference for the social novelty test was used as previously described by
Sala et al.32 After 10min habituation to the cage, an unfamiliar male mouse
was enclosed in one side comportment, whereas the opposite side
contained an empty wire cage. For the social novelty test, carried out in the
same apparatus immediately after the sociability test, one side compart-
ment contained the familiar mouse (from the previous sociability phase),
and the other side an unfamiliar mouse. For both tests the time spent and
the number of entries made in each chamber were recorded for 10min.
Data were expressed as the difference score between the time spent to
explore the compartment containing the familiar mouse and that spent in
the empty compartment (for sociability test), or containing the stranger
animal and that for the familiar mouse (for social novelty test).
EEG
After surgery (See Supplementary Materials and Methods), EEG activity was
recorded in a Faraday chamber, using a Power-Lab digital acquisition
system (AD Instruments, Bella Vista, NSW, Australia; sampling rate 100 Hz)
in freely moving mice.
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Basal 24-h recording. For basal cerebral activity, freely moving mice were
recorded for 24 h. For each 24-h EEG recording, the mean number of spikes
was evaluated in both genotypes. EEG traces were sampled at 100 Hz. 20,33
Chronic VLP. Twenty-four hours after the last intake of VLP, given for
21 days, mice were recorded weekly for 2 h during 3 weeks.
Western blot analysis
Western blot was carried out as previously described.21 Homogenates of
hippocampi and prefrontal cortex from SNAP-25+/− mice (immediately
after VLP withdrawal and after 3 weeks) were separated by electrophoresis,
blotted on nitrocellulose membrane and analysed using monoclonal
antibodies against SNAP-25 (Sternberger Monoclonals, Lutherville,
MD, USA; 1:100 000) and anti-beta-III-tubulin (Promega, Madison,
WI, USA, 1:4000). Membranes were washed and incubated for 1 h at
room temperature with the secondary antibody IRDye 680-conjugated
goat anti-mouse (LI-COR Biosciences, Lincoln, NE, USA; diluted 1:10 000)
or IRDye 800-conjugated goat anti-rabbit (LI-COR Biosciences; diluted
1:10 000) and then scanned using an Odyssey Infrared Imaging System
(LI-COR Biosciences). Alternatively, immunoreactive bands were
detected using the Pierce ECL Western Blot Substrate (Thermo Fisher
Scientiﬁc, Rockford, IL, USA), scanned with GS-800TM calibrated densi-
tometer (Bio-Rad Laboratories, Segrate, Italy), and analysed with Image J
Software (National Institutes of Health, Bethesda, MD, USA). For each
sample, SNAP-25/beta-III-tubulin pixel values were normalized to the
average of SNAP-25+/+ controls.
Statistical analyses
For human studies, χ2-analysis was used to exclude any deviation of SNP
genotype distribution from the Hardy–Weinberg equilibrium (P-value was
40.05 both in cases and in controls). The χ2-statistics or Fisher's exact test,
as appropriate, were applied to contingency table (2XN) to compare: case–
control differences of SNP distributions, as well as EEG alteration with or
without seizures in ASD patients in relationship with SNPs. Cognitive
degree distribution was ﬁrst evaluated in relationship with the SNP
genotype by contingency table clustering as categorical variables with
lower scores from 1 to 3 (1 = profound mental retardation, 2 = severe
mental retardation, 3 =moderate mental retardation) and higher scores
from 4 to 6 (corresponding to lower cognitive deﬁcit, 4 =mild mental
retardation, 5 = borderline cognitive level and 6= normal functioning), and
then a more in depth analysis was performed by numerical degrees scores
association with SNPs by analysis of variance. All the numerical variables
evaluated resulted normally distributed after the Kolmogorov–Smirnov
test analysis. Analysis of variance calculation was applied to CARS, autism
degree and hyperactivity score (two speciﬁc items derived from CARS). For
luciferase and animal studies, data were given as mean± s.e.m. and
analysed by one-way or two-way analysis of variance for repeated
measures followed by Tukey’s or Bonferroni’s post hoc tests, when
appropriate. Pair-wise comparisons between genotypes or treatments
were assessed using the Student’s t-test. All statistical analyses were done
with software Prism, version 6 (GraphPad, San Diego, CA, USA) using a
critical probability of Po0.05. Statistical analyses performed for each
experiment were summarized in each legend of the ﬁgures with the
chosen statistical test, n and P-values, as well as degree of freedom and F/t
values.
RESULTS
Human studies
The rs363050 gene polymorphism correlates with decreasing
cognitive scores in autistic children.
The genotype distribution of the ﬁve analysed SNAP-25 SNPs
(rs363050(A/G), rs363039(G/A) rs363043(C/T), rs3746544(T/G) and
rs1051312(T/C)) was in the Hardy–Weinberg equilibrium. SNAP-25
genotypes were then examined in relationship with the CARS
score34 in toto (range: 15–60), as well as in relationship with the
speciﬁc scores assigned to hyperactivity (CARS’ item 13) and
autistic core-behaviour (CARS’ item 15). The latter are speciﬁc
items of the CARS, meant to separately deﬁne hyperactivity level
and autistic core-behaviour on a seven-step scale (ranging from 1,
meaning ‘normal for child’s age’, to 4 ,‘severely abnormal for
child’s age’, with increases of 0.5). Moreover, based on the
hypothesis that brain dysfunctions could be inferred from a lower
cognitive functioning and/or from cortical electrical abnormalities,
patients were subsequently classiﬁed according to their cognitive
levels using the DSM IV-TR criteria.28 Categorical variables were
evaluated by contingency table and χ2-evaluation.
Signiﬁcant associations of the rs363050 polymorphism with
altered cognitive scores was observed by the comparison of
categorical cognitive score variables (P= 0.005 after correction for
2 degrees of freedom (df)) (Table 1): in particular, rs363050(GG)
genotype was more frequently observed in subjects with lower
cognitive scores (1–3) than in subjects with higher cognitive
scores (0.75 vs 0.25) (Table 1). Cognitive score association with
SNAP-25 polymorphism was further analysed by numerical
degrees scores association with SNPs by analysis of variance.
Also, in this case results showed a statistical association between
rs363050 polymorphism distribution and cognitive scores, index
of mental retardation, whereas no associations were observed
between these SNPs and any of the other neuropsychiatric
parameters analysed. Finally, the analysis of possible correlations
between cortical electrical dysfunction (classiﬁed as: EEG abnor-
malities (+/− ) and presence of seizures (SEIZ) (+/− ) (EEG− /
SEIZ− ; EEG+/SEIZ− ; EEG− /SEIZ+; EEG+/SEIZ+) and SNAP-25 SNPs
Table 2. Distribution of the rs363050(A/G), rs363039(G/A) and
rs363043(C/T), rs3746544(TG) and rs1051312(TC) genotypes evaluated
in children with autism spectrum disorders
EEG− /
SEIZ− , N
Freq
EEG
+/SEIZ− , N
Freq
EEG+/SEIZ
+, N Freq
df c2 P-value
rs363050
AA (18) 15 (0.83) 2 (0.11) 1 (0.06)
AG (18) 14 (0.77) 3 (0.17) 1 (0.06)
GG (8) 6 (0.74) 1 (0.13) 1 (0.13)
3 0.73 0.95
rs363039
GG (18) 16 (0.89) 1 (0.05) 1 (0.05)
GA (22) 16 (0.73) 4 (0.18) 2 (0.09)
AA (4) 3 (0.75) 0 1 (0.25)
3 3.58 0.46
rs363043
CC (20) 15 (0.75) 3 (0.15) 2 (0.10)
CT (22) 18 (0.82) 3 (0.14) 1 (0.04)
TT (2) 2 (1.00) 0 0
3 1.07 0.89
rs3746544
TT (17) 15 (0.88) 1 (0.06) 1 (0.06)
TG (23) 17 (0.74) 4 (0.17) 2 (0.09)
GG (4) 3 (0.75) 1 (0.25) 0
3 2.04 0.63
rs1051312
TT (25) 20 (0.80) 4 (0.16) 1 (0.04)
TC (17) 13 (0.76) 2 (0.12) 2 −12
CC (2) 2 (1.00) 0 0
3 1.58 0.81
Abbreviations: df, degrees of freedom; EEG, electroencephalogram; SEIZ,
seizures. Children (44) were classiﬁed based on the degree of cognitive
impairment and on the degree of cortical electrical dysfunction. Cortical
dysfunction: lack of EEG abnormalities and absence of seizures (EEG− /
SEIZ− ), presence of EEG abnormalities without seizures (EEG+/SEIZ− ),
seizures without interictal EEG abnormalities (EEG− /SEIZ+) and presence
of both EEG abnormalities and seizure (EEG+/SEIZ+). N= number of
patients. Values are expressed as frequencies. P-value with Bonferroni
correction.
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as categorical variables, by contingency table and χ2-evaluation
(Table 2), did not reveal the presence of any further association.
In vitro studies
SNP rs363050 encompasses a regulatory element leading to
SNAP-25 expression decrease.
The results obtained in humans studies reported a strong
association between SNAP-25 SNP rs363050 polymorphism and
cognitive functions. rs363050 SNP is localized in intron 1 of the
gene coding for SNAP-25; as regulatory elements are often
present in introns of genes,35–38 we conducted, by means of the
luciferase reporter gene assay, an analysis of rs363050 SNP
functional effect on transcriptional activity with the aim to deﬁne
whether it could have a key role in the SNAP-25 gene expression. A
series of plasmids, in which the region encompassing the
rs363050 SNP and carrying either the parental (A) or the minor
allele (G) was inserted in single or four concatenated copies
upstream and/or downstream the thymidine kinase (TK) promoter
in pGL4 basic vector, were originated (Figures 1a and b). Their
activity was tested by means of transient transfection of the
human neuroblastoma SH-SY5Y cell line and compared with that
of the plasmid without the cassette (Figures 1a and b, TK-luc/pGL4
basic). The A allele did not affect transcription regulation of the
reference plasmid (Figure 1a, rs363050A-TK-luc vs TK-luc) when
present in single copy, but had a slight, although statistical
signiﬁcant increase when in four copies (Figure 1b). The presence
of the susceptible G allele resulted in a statistical signiﬁcant
decrease in luciferase (luc) activity of 30% (Figure 1a, Po0.001)
and 42% (Figure 1b, Po0.001), respectively. When the same
cassettes were inserted downstream the luc reporter gene, both
constructs (TK-luc-rs363050A and TK-luc-rs363050G) showed a
marked decrease in the capability of driving the expression of the
reporter gene of 60% (Po0.001) with respect to the TK promoter
(Figure 1a, grey and hatched bar vs black bar). However, the
reduced transcription capability of the minor allele (G) with
respect to the parental allele (A) was again observed (Figure 1a,
construct TK-luc-rs363050A vs TK-luc-rs363050G, 31% reduction,
Po0.001). As a control, three concatenated copies of the
sequence, surrounding the rs363043 polymorphic site, were
tested (Figure 1c). No effect on transcription was measured in
the presence of both the parental allele (C) and minor allele (T).
Expression level relative to TK-luc (=1)
Expression level relative to TK-luc (=1)
Expression level relative to TK-luc (=1)
1.5
0.0 1.5
$$$**
*
*
*
*
X
X
1.5
*
*
*
$$$
1.00.5
0.0 1.00.5
0.0 1.00.5
Figure 1. Functional effect of rs363050 single-nucleotide polymorphism (SNP). SNP rs363050 contains a regulatory element leading to
synaptosomal-associated protein of 25 kDa (SNAP-25) expression decrease. (a) The presence of the parental allele (A), when cloned in single
copy upstream the thymidine kinase (TK) promoter (construct rs363050A-TK-luc) did not increase the activity of the heterologous TK
promoter (white bar vs black bar), whereas the presence of the minor allele (G) (construct rs363050G-TK-luc) signiﬁcantly affected by 33% the
activity of the promoter (F(4,10)= 234.8, P= 0.001, one-way analysis of variance (ANOVA)). (b and c) The region surrounding the rs363050 and
rs363043 SNP was cloned in four and three concatenated copies, respectively. Left: schematic illustration of the constructs. The black boxes
represent the HSV-TK promoter, the white boxes in panel A the 747 bp region of SNAP-25 gene intron 1 spanning rs363050 SNP, the grey oval
represent the Fireﬂy luciferase reporter gene (luc). The black cross indicates the (A) to (G) change; the arrows indicate the transcription start
site. Right: luciferase assays. SH-SY5Y cells were transiently transfected with the constructs shown on the left. The bars show the
transcriptional activity of the constructs expressed as a relative expression level of luciferase normalized to that of renilla with respect to the
TK-luc construct (= 1), and expressed as mean values± s.d. of at least three independent experiments performed in triplicate. The three
asterisks indicate a statistically signiﬁcant difference between rs363050A and rs363050G constructs (one-way ANOVA). In a, $$$ indicates a
statistically signiﬁcant difference between TK-luc/pGL4 basic and TK-luc-rs363050A construct (one-way ANOVA, Po0.001); in b it indicates a
statistically signiﬁcant difference between four rs363050A and rs363050G copy constructs (one-way ANOVA, Po0.001).
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Animal studies
Experiment 1. Adolescent SNAP-25+/− mice are impaired in
motor activity, memory, social interaction and show reduced
SNAP-25 expression: therapeutic effect of VLP.
Given the SNP rs363050(G) was strongly associated with
cognitive scores in ASD children and since the rs363050 minor
allele displayed a reduced transcription capability, we evaluated
the behavioural proﬁle of 6-week-old SNAP-25+/− mice in order to
deﬁne whether reductions of the protein levels could affect the
cognitive proﬁle in young individuals. Furthermore, as acute
treatment with VLP has been previously demonstrated to abolish
associative memory defects in adult SNAP-25+/− mice,21 animals
were exposed to plain water or VLP, for 21 days, 24 h per day. The
mean daily intake was not different between VLP- and water-
exposed mice. The VLP amount corresponded to 250–270mg-
kg− 1 per day (Supplementary Figure 2).
Analysis of motor activity was carried out in mice of both
genotypes in basal conditions and after chronic VLP treatment. The
time course of horizontal activity, recorded every 10min for 4 h
(baseline) and after D-amphetamine injection for 3 h after water or
VLP pre-exposure, is reported in Supplementary Figure 2. Analysis
of the time course (Figure 2a), evaluated as blocks of 1-h each,
showed that SNAP-25+/− mice were hyperactive. Amphetamine
treatment signiﬁcantly increased the number of horizontal move-
ments in SNAP-25+/+ water-exposed mice, but it was ineffective in
SNAP-25+/− mice. Any difference among the groups on the mean
horizontal activity counts after VLP was shown, conﬁrming that the
drug normalized motor activity in the SNAP-25+/− mice.
When tested for CTA with saccharin (Figure 2b), SNAP-25+/−
mice exhibited a signiﬁcantly attenuated CTA, as they avoided the
saccharin solution to a lesser degree compared with SNAP-25+/+
mice during choice tests. Repeated treatment with VLP induced a
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signiﬁcant decrease in saccharin intake in the SNAP-25+/− mice
compared with the water-exposed controls without affecting the
intake of sweet solution in wild-type animals, suggesting a
recovery in CTA. Mutant and control mice drank comparable
amounts of ﬂuid during the conditioning sessions (not shown),
excluding a general alteration of ﬂuid consumption or taste.
When tested for sociability, SNAP-25+/+ water-exposed mice
appeared normal, spending longer time to explore the compart-
ment with the stranger mouse than the empty cage. Conversely,
SNAP-25+/− mice, pre-exposed to water, spent more time in the
empty compartment (Figure 2c). When tested for social recogni-
tion (Figure 2d), SNAP-25+/− mice remained close to the familiar
stranger for the same time, suggesting an impaired social
recognition. Both genotypes spent equal time in the central
compartment. Pre-treatment with chronic VLP signiﬁcantly
rescued both sociability and social novelty deﬁcits.
SNAP-25+/− adolescent mice were impaired in episodic
memory, as indicated by the altered discrimination index in the
novel object recognition test (Figure 2e). SNAP-25+/− mice
exposed to water exhibited a reduced discrimination index
compared with their littermates. VLP exposure slightly, but not
signiﬁcantly, decreased SNAP-25+/+ performance, whereas it was
able to signiﬁcantly recover SNAP-25+/− mice deﬁcit.
Western blotting analysis of SNAP-25 expression in the
hippocampi and prefrontal cortex of 6–7-week-old mice, water
exposed, revealed a reduction of about 30 and 20% expression in
SNAP-25+/− tissue relative to wild type, respectively (Figure 3f,
right), in line with previously reported ﬁndings evaluated in the
cortex.21 Chronic treatment with VLP completely rescued, only in
the hippocampi, expression in SNAP-25+/− . These ﬁndings open
the possibility that the behavioural rescue observed in SNAP-25+/−
mice upon VLP treatment might be at least partially associated
with increased protein levels.
Experiment 2. Basal EEG activity is characterized by spike activity
in adolescent SNAP-25+/− mice: VLP normalizes at least for 1 week
the EEG recording.
In basal conditions, adolescent SNAP-25+/− mice displayed EEG
abnormalities in terms of spike activity during 24-h recording
(Figure 3a), as previously shown also in the adult heterozygous
mice.21 Two representative traces (Figure 3b) of one SNAP-25+/+
(left) and one SNAP-25+/− mouse (right) are reported. In basal
conditions SNAP-25+/+ tracing appeared normal, whereas that of
SNAP-25+/− mouse was characterized by an abnormal and
recurrent increase of amplitude. Twenty-four hours after chronic
21-day VLP exposure, heterozygous tracing was normalized. VLP
pre-exposure had no effects on the wild-type EEG proﬁle. The
quantitative analysis of the mean number of spikes, evaluated for
2 h and in the following 3 weeks after VLP withdrawal in both
genotypes (Figure 3c, left), revealed a reduction of spikes in
SNAP-25+/− mice during the ﬁrst week, which progressively
returned to basal value within the third week. Accordingly, a
15% decrease of SNAP-25 expression in heterozygous hippocampi
was shown after VLP withdrawal.
DISCUSSION
The goal of the present study was to obtain supportive evidence
for association between SNAP-25 gene and ASD-speciﬁc scores,
using multiple strategies. First, we found that among ﬁve SNPs in
the SNAP-25 gene, the SNPs rs363050 showed signiﬁcant relation
with altered cognitive scores in ASD children. Our ﬁndings agree
with others,39 where an association between rs363050 putative
risk allele with intellectual disability traits was suggested. Different
SNAP-25 gene polymorphisms have been suggested to associate
with related traits of autism17 and ADHD,40 working memory
ability41 including short-/long-term memory and visual
attention.16 We cannot exclude a linkage disequilibrium effect or
an ethnic effect, which may explain the involvement of different
SNPs in the same SNAP-25 genetic locus. For this reason
replication studies using larger case studies are warranted.
In this study, we performed a more in depth analysis of the
possible functional role of rs363050 SNP to better understand its
involvement in SNAP-25 expression. The analysis of transcriptional
activity revealed that SNP rs363050 spans a region containing a
regulatory element whose function is dependent on its position;
furthermore, the presence of the minor allele rs363050(G)
inﬂuences the transcription of the SNAP-25 gene. This could be
Figure 2. Behavioural proﬁle and synaptosomal-associated protein of 25 kDa (SNAP-25) expression of SNAP-25+/+ and SNAP-25+/− mice
evaluated 24 h after sodium valproate salt (VLP) (1 mgml− 1) or water exposure for 21 days. (a) The mean (± s.e.m.) of horizontal movements
recorded every 10 min in the last 2 h of basal (pre) and every hour after amphetamine (4mg kg−1) treatment for 3 h (two-way analysis of
variance (ANOVA) (genotype as a between-subject factor: F(3,126)= 4.06; P= 0.01; time as a within-subject factor: F(3,126)= 30.95; P= 0.0001;
treatment ×genotype interaction: F(9,126)= 20.10, Po0.0001). ***Po0.001 vs SNAP-25+/+ water-exposed mice, same interval; °°Po0.01,
°°°Po0.001 vs corresponding pre; $$Po0.01, $$$Po0.001 vs SNAP-25+/− water-exposed mice, same interval (Bonferroni post hoc test). (b)
Conditioned taste aversion (CTA). Mice were exposed to saccharin solution (0.5%) followed, 1 h later, by a malaise-inducing injection of LiCl
(0.14 M, 2% body weight, intraperitoneally). A lack of CTA was shown in SNAP-25+/− mice (genotype as a between-subject factor: F
(1,36)= 73.38; Po0.0001; treatment as a within-subject factor: F(1,36)= 4.82, P= 0.03; genotype × treatment: F(1,36) = 27.84; Po0.0001, two-
way repeated measure ANOVA). ***Po0.001 compared with SNAP-25+/+ water-exposed mice; &Po0.05 compared with SNAP+/− water-
exposed mice (Bonferroni post hoc test). (c–d) Difference score (mean± s.e.m.) in terms of time difference spent in the chamber associated
with the never-seen-before mouse and empty cage or familiar mouse (preference for social novelty test). There was a difference among
groups for sociability: (genotype as a between-subject factor: F(1,36)= 42.94; Po0.0001; treatment as a within-subject factor: F(1,36)= 33.93;
Po0.0001; genotype × treatment: F(1,36)= 16.88; P= 0.0002, two-way ANOVA for repeated measures of variance). There was a difference
among groups for social novelty (genotype as a between-subject factor: F(1,36)= 188.8; Po0.0001; treatment as a within-subject factor: F
(1,36)= 32.09; Po0.0001; genotype × treatment: F(1,36)= 6.62; P= 0.001, two-way repeated measure of variance). ***Po0.001 compared with
water-exposed SNAP-25+/+ mice; °°Po0.01, °°°Po0.001 compared with SNAP+/− water-exposed mice (Bonferroni post hoc test). (e) Object
recognition task. Discrimination index (mean± s.e.m.), evaluated 120min after mice were presented with a familiar and a new object, was
different among groups (two-way ANOVA: genotype as a between-subject factor: F(1,36)= 0.50, P= 0.48; treatment as a within-subject factor:
F(1,36)= 5.16; P= 0.02; genotype × treatment: F(1,36)= 100.9, P= 0.0001). *Po0.05, ***Po0.001 compared with water-exposed SNAP-25+/+
mice; °°°Po0.001 vs SNAP-25+/- water exposed (Bonferroni post hoc test). (f) SNAP-25 expression in the hippocampus and prefrontal cortex of
6-week-old mice pre-exposed to water or VLP for 21 days. Western blotting analysis and relative quantitation, carried out in SNAP-25+/− water-
exposed mice, showed reduced SNAP-25 expression, signiﬁcantly only in hippocampus, and a recovery of SNAP-25 expression after VLP
treatment (genotype as a between-subject factor: F(1,17)= 9.66, P= 0.006; treatment as a within-subject factor F(1,17)= 2.56; P= 0.12;
genotype × treatment F(1,17)= 7.53; P= 0.01). n= 5/6 for each group (genotype as a between-subject factor: F(1,16)= 7.01, P= 0.001;
treatment as a within-subject factor F(1,16)= 0.88; P= 0.36; genotype × treatment F(1,16)= 0.88; P= 0.35). n= 5/6 for each group. No signiﬁcant
changes in prefrontal cortex were shown **Po0.001 compared with SNAP-25+/+ water-exposed mice; &Po0.05 vs SNAP-25+/- water exposed
(Bonferroni test).
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Figure 3. Synaptosomal-associated protein of 25 kDa (SNAP-25+/− ) mice showed abnormal electroencephalogram (EEG), which was rescued
by VLP at least for 1 week. (a) Spike activity (mean± s.e.m.) in basal conditions evaluated every hour during the 24-h recording. **Po0.01
compared with SNAP-25+/+ mice. (b) Effect of exposure to sodium valproate salt (VLP) or water for 21 days evaluated in two representative
mice for 2 h, evaluated 24 h after the end of the exposure. Two-way analysis of variance (ANOVA) showed differences among the groups
(genotype as a between-subject factor: F(1,40)= 62,51, Po0.0001; time as a within-subject factor: F(4,40)= 6,415; Po0.001; genotype × time F
(4,40)= 6.39; Po0.001). (c) Quantitative analysis of mean (± s.e.m.) number of spikes evaluated every week for 3 weeks after exposure
cessation. ***Po0.001 vs baseline SNAP-25+/− mice. °°Po0.05, °°°Po0.001 vs corresponding SNAP-25+/+ mice (Bonferroni post hoc test). (d)
Western blotting analysis and relative quantiﬁcation of SNAP-25 levels in SNAP-25+/− hippocampi evaluated immediately and 3 weeks after
VLP withdrawal. N= 5 for each genotype. **P o0,0038 (Student's t-test).
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due to the impairment of binding of factors involved in the
modulation of the SNAP-25 gene expression level or in the binding
of other factors, different from the ones that recognize the
sequence of the parental allele, acting as a repressor. Due to the
importance that the presence of the minor allele can have on
SNAP-25 expression levels, experiments aimed to identify and
characterize this factor will be further exploited. SNAP-25 has a
central role in synaptic transmission and plasticity.4,40,42,43 The
protein forms a complex with syntaxin and the synaptic vesicle
proteins (synaptobrevin and synaptotagmin), which is required for
the Ca++-mediated exocytosis of the neurotransmitter into the
synaptic cleft. The protein is also involved in the processes of axon
growth44 and dendritic spine morphogenesis.45 Changes in the
levels of expression of the SNAP-25 protein may inﬂuence the
functioning of synaptic circuits associated with cognitive
functions.
Our ﬁndings on adolescent SNAP-25+/− mice strongly corrobo-
rate the association between SNAP-25 and cognitive function. A
signiﬁcant impairment in different forms of memory was found
when SNAP-25 protein expression was reduced. Memory deﬁcits
were observed in three different forms of memory: episodic,
aversive and social. About the latter, social recognition disability
was accompanied by a decrease of social interaction, suggesting
an autistic-like trait.
ASD are often accompanied by co-morbidity including hyper-
activity (40%) and seizures (30%), which are clinical features
shared with ADHD.46 A signiﬁcant correlation between SNAP-25
gene polymorphism and hyperactivity in a cohort of children with
a diagnosis of ASD has been previously found.17 Interestingly, the
behavioural proﬁle of adolescent SNAP-25+/− mice conﬁrmed
hyperactivity, as previously shown in mice of the same age,21 and
we believe revealed for the ﬁrst time abnormal EEG characterized
by frequent spikes of high amplitude, already in very young mice.
Notably, comparing the behavioural deﬁcit previously observed in
adults,21 adolescent SNAP-25+/− mice showed a similar cognitive
deﬁcit but a greater impairment of social behaviour and social
recognition. In contrast, EEG abnormality was less pronounced in
adolescent SNAP-25+/− mice. These ﬁndings are in line with what
happens in autistic patients. Findings on intellectual functioning
outcome in autistic adulthood revealed that intelligence quotient
scores tend to remain stable overtime in the majority of studies.47
More difﬁcult is the comparison between mice and patients about
social behaviour: large individual differences were found, although
autism-related symptoms and behaviour generally improve with
age.47 Epilepsy increases with age48,49 and the cumulative risk of
epilepsy in adults with autism is estimated at 20–35%.50 The
abnormal EEG activity could be a factor contributing to learning
(see Corradini et al.21 for discussion) and is indeed well established
that epileptiform EEG discharges unaccompanied by overt clinical
change may be associated with transitory cognitive impairment
detectable by appropriate psychological testing;51 also, a decline
in intelligence quotient score in patients affected by epilepsy has
been reported.52
Repeated exposure to VLP, largely normalized, as expected, the
altered EEG proﬁle but, surprisingly, it exerted positive effects on
all behavioural deﬁcits, including hyperactivity. VLP is known to
have a broad spectrum of actions: it reduces neuronal excitability
regulating the glutamate/GABA neurotransmitters system and
modulating the synaptic/inhibitory balance. This modulation has
been recently linked to its indirect action through astrocytes.53 In
addition, VLP is an histone deacetylase inhibitor and also induces
brain-derived neurotrophic factor and glial cell-line-derived
neurotrophic factor NF transcription/expression in astrocytes to
provide a consequent neuroprotective effect in vitro.54
We observed detrimental effects induced by prolonged
exposure to VLP in SNAP-25+/+ mice on object recognition and
slightly on CTA. VLP can interfere with learning and memory
processes both in experimental models55,56 and patients.57,58
Indeed, it has been reported to alter spatial learning in immature
rats via the activation of protein kinase Cγ in hippocampal
neurons.54 Altered dendritic morphology and impaired social
transmission of food preference in epileptic mutant mice,56 after
3 months of exposure to oral VLP (100 mg per 100 ml), have also
been found. On the other hand, VLP reduced seizures, mortality
and rescued a normal hippocampal long term potentiation in the
same mice, in which severe seizures occurred in the early period
of their life.56
Interestingly, in our experiments, VLP was able to rescue the
decreased SNAP-25 expression into the hippocampus, suggesting
the possibility of a direct effect on the protein expression levels.
The mechanism by which VLP acts on SNAP-25 expression
remains unclear. Hippocampus is an area strongly involved in
different forms of memory. Future studies will be needed to
evaluate the SNAP-25 level expression in other areas involved in
motor function and sociability, such as striatum and amygdala.
In conclusion, our current data, together with a previous study
carried out in adult SNAP-25+/− mice,21 suggest that reduced
levels of SNAP-25 protein expression are responsible for
behavioural and EEG alterations in adolescent mice. Given
rs363050(G), which associates with altered cognitive scores in
ASD children, leads to reduced protein expression, one could
support our previous hypothesis that the reduction of SNAP-25
expression could be involved in the cognitive and neuropsycho-
logical deﬁcits in children affected by ASD.59
Notably, beside the autistic symptoms, SNAP-25+/− mice show a
broad spectrum of deﬁcits that mimic the well-known neuropsy-
chiatric or neurologic disorders, such as ADHD, schizophrenia and
epilepsy. In this context, VLP appears to gain signiﬁcant attention
for its potential therapeutic use. The potential mechanism through
which alterations in SNAP-25 may have a direct role in the
aetiology as well as contribute to the pathology of these disorders
requires future studies.
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